Northfield Bancorp, Inc.
NFBKNasdaqFinancials · Savings Institution, Federally Chartered · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.9M | $6.4M | $5.5M | $5.7M | $5.4M | $4.0M |
| Operating income | — | — | — | — | — | — |
| Net income | $796,000 | $29.9M | $37.7M | $61.1M | $70.7M | $37.0M |
| Total assets | $5.75B | $5.67B | $5.60B | $5.60B | $5.43B | $5.51B |
| Total liabilities | $5.06B | $4.96B | $4.90B | $4.90B | $4.69B | $4.76B |
| Equity | $690.1M | $704.7M | $699.4M | $701.4M | $739.9M | $754.0M |
| EPS (diluted) | $0.02 | $0.72 | $0.86 | $1.32 | $1.45 | $0.76 |
| Shares out. | 43.1M | 44.5M | 46.8M | 48.9M | 51.8M | 49.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 11.6%
- Return on equity
- 0.1%
- Return on assets
- 0.0%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 88.0%
- Debt / equity
- 7.34×
- Book value / share
- $16.00
- Revenue growth (YoY)
- 6.8%
- Net income growth (YoY)
- −97.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −0.9%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 27, 2026
- Dimensional Fund Advisors LpPassive (13G)Jan 21, 2026
- Blackrock Portfolio Management LlcPassive (13G)Apr 21, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Fasanella DavidOfficer — EVP | Mar 19, 2026 | Buy | 7,500 | $13.07 |
| Stahlin PaulDirector | Mar 17, 2026 | Buy | 10,000 | $13.19 |
| Stahlin PaulDirector | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Patafio Frank P.Director | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Jacobs William R.Officer — EVP & PAO | Feb 4, 2026 | Grant | 7,944 | $13.69 |
| Chapman GilDirector | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Lefkowitz RobinOfficer — EVP | Feb 4, 2026 | Grant | 6,939 | $13.69 |
| Connors John P JrDirector | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Catino AnnetteDirector | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Tomasello VickieOfficer — EVP/Chief Risk Officer | Feb 4, 2026 | Grant | 6,483 | $13.69 |
| Kulkarni Rachana ADirector | Feb 4, 2026 | Grant | 4,383 | $13.69 |
| Fasanella DavidOfficer — EVP | Feb 4, 2026 | Grant | 7,533 | $13.69 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 736,619 | 3.9 | -0.0% |
| Apr 30, 2026 | 736,760 | 4.0 | -1.9% |
| Apr 15, 2026 | 751,361 | 2.8 | -2.0% |
| Mar 31, 2026 | 767,049 | 2.1 | +6.2% |
| Mar 13, 2026 | 722,510 | 2.5 | +14.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Other material eventApr 21, 2026
- Director / officer changeFeb 6, 2026
- Results of operations · Regulation FD disclosureFeb 3, 2026
- Entered a material agreement · Director / officer change · Regulation FD disclosureFeb 2, 2026
- Regulation FD disclosureNov 10, 2025
- Results of operations · Other material eventOct 23, 2025
- Results of operations · Other material eventJul 25, 2025
- Shareholder voteMay 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- DEFM14AMay 21, 2026
- 10-QMay 11, 2026
- 10-K/AApr 28, 2026
- 8-KApr 21, 2026
- SCHEDULE 13G/AMar 27, 2026
- 4FORM 4Mar 20, 2026
- 4FORM 4Mar 19, 2026
- 10-KMar 2, 2026
- 8-K/AFeb 9, 2026
- 4/AFORM 4/AFeb 6, 2026
- 4/AFORM 4/AFeb 6, 2026
- 4/AFORM 4/AFeb 6, 2026
- 4/AFORM 4/AFeb 6, 2026
- 4/AFORM 4/AFeb 6, 2026
- 4/AFORM 4/AFeb 6, 2026